Skip to main contentBack to Top

Researchers in the Cancer Immunology research program use a range of techniques to study how the immune system influences tumorigenesis and cancer therapy. The immune system can inhibit or promote tumor progression in local tissues where pre-malignancies form. Major program themes are to elucidate

  • How pre-malignancies create and sustain local immunologic tolerance necessary for tumor formation
  • How to destroy local tolerance that protects tumors from natural and vaccine-induced anti-tumor immunity.

The scientific rationale for this dual approach is that pre-malignant cells create and sustain tolerance during tumor progression, while breaking tumor-associated tolerance is necessary for successful anti-tumor treatment. Hence, program goals are to elucidate molecular and cellular pathways at sites of inflammation that promote or break immune tolerance using pre-clinical mouse models of tumor progression and autoimmune syndromes, and developing novel immunotherapies to treat these syndromes more effectively by targeting tolerance pathways. To this end, program faculty also engage in promoting pre-clinical research and early-phase clinical trials of novel vaccine adjuvants to improve cancer immunotherapy, in some cases with corporate partners.

To pursue these focused research themes and scientific goals, program faculty employ many state-of-the-art techniques, facilities, and unique resources, including flow cytometric sorting and analysis, a range of molecular imaging techniques, genomic analysis, and genetically modified mouse strains. Future program development will build on existing CIT program strengths by recruiting new investigators with expertise in inflammation, immunological, and metabolic research to complement current research focused on regulation of adaptive immunity.


photo of Yan Cui, PhD

Yan Cui, PhD

  • Professor
photo of Rafael Czepielewski, Ph.D.

Rafael Czepielewski, Ph.D.

  • Assistant Professor
photo of Yukai He, MD, PhD

Yukai He, MD, PhD

  • Professor

I was trained as a physician, but has been fascinated by how our body’s immune system has been so effective to control not only microbial infections, but also cancer cells. We had studied the basic mechanism of how cancer vaccines activated immune responses and applied the vaccine design technologies into developing liver cancer vaccines. Over the last decade, research in my lab has been focusing on identifying novel T cell receptors (TCR) and on developing new chimeric antigen receptors (CAR) for liver cancer immunotherapy. We are fortunate that our research has been continuously funded by NCI/NIH grants. Our goal is to engineer immune T cells to become potent and targeted fighters to eliminate cancer cells and cure cancer patients.

photo of Bangxing Hong, PhD

Bangxing Hong, PhD

  • Assistant Professor
photo of Theodore S. Johnson, MD, PhD

Theodore S. Johnson, MD, PhD

  • Associate Professor
photo of Balveen Kaur, PhD

Balveen Kaur, PhD

  • Professor
photo of Zoya C. Kurago, DDS, PhD

Zoya C. Kurago, DDS, PhD

  • Associate Professor
photo of Kebin Liu, PhD

Kebin Liu, PhD

  • Professor
photo of David Munn, MD

David Munn, MD

  • Professor
photo of Marco Orecchioni, PhD

Marco Orecchioni, PhD

  • Assistant Professor
photo of Rafal Pacholczyk, PhD

Rafal Pacholczyk, PhD

  • Assistant Professor
photo of Gang Zhou, PhD

Gang Zhou, PhD

  • Professor
photo of Yangfang "Peipei" Zhu, PhD

Yangfang "Peipei" Zhu, PhD

  • Assistant Professor

Cancer Research News

A male medical researcher wearing a white medical coat and blue gloves looks into a machine with lots of plastic tubes.

Medical College of Georgia researcher awarded $2.8 million NCI grant

The grant awarded for Chadli’s research focuses on a specific protein, UNC45A, that can be used as a promising novel immunotherapeutic target in treating triple-negative breast cancer (TNBC).

People in white coats walking across college campus

High school students explore research careers with Georgia Cancer Center summer program

This summer, high school students participated in the Georgia Cancer Center's first Summer Research Experience Program.

Man in a blue polo shirt stands beside the M. Bert Storey Research Building sign

Georgia Cancer Center researcher studies dangers of living in a food swamp

It is a key to life, but not every person living in Augusta has the same access to healthy food as their neighbors across the region.

two men and a woman standing in a science lab smiling for the camera

Inhalant CBD offers hope in fight against lung cancer, Augusta University study finds

A study conducted by a team of researchers from the Dental College of Georgia at Augusta University tested inhalant CBD in the treatment of lung cancer and whether it could inhibit tumors from growing or spreading.